Atlas Trials

Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND)

Clinical trial NCT06518720 · RECRUITING

Trial details

NCT number
NCT06518720
Sponsor
Centre for Addiction and Mental Health
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Treatment Resistant DepressionChronic Pain
Start date
2025-04-01
Primary completion
2027-03-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.